1067059

Asclemed USA Inc. dba Enovachem Pharmaceuticals — FEI 3001452204

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
September 27, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Torrance, CA (United States)